Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...
In March, techUK’s TechTogether campaign will return, following the great success of our 2025 campaign and the ongoing DEI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback